A Versatile Dinuclear Palladium ꢀ-Diiminate Complex
Organometallics, Vol. 27, No. 6, 2008 1297
Figure 8. The structures of two Cu-Cl clusters: from molecule 6A (left) and from molecule 6B (right). The [Pd(Ph2nacnac)(L1)2]+ fragments
have been reduced to a connecting ꢀ-C atom.
overnight. The clear, colorless liquid was decanted leaving dark
green needle crystals that were dried in air to give 1 in 65% yield
(51 mg). The crystals obtained were suitable for X-ray crystal-
solution of 1 for 15–20 min. To obtain the NMR spectra, CO was
bubbled through a green solution of 1 (28 mg) in CD2Cl2 in a J.
Young NMR tube. After 15 min the tube was closed and the
collected spectra confirmed a full conversion of 1. For the IR
measurements, CO was bubbled through a solution of 1 in either
CCl4 or toluene for 20 min. The crystals suitable for X-ray
crystallographic analysis were obtained by adding pentane
saturated with CO to a solution of 4 in toluene in a vial under
a blanket of CO. The pale red solution was then cooled in the
freezer (-30 °C) to produce the crystalline 4 within a few hours.
1H NMR (CD2Cl2) δ 1.79 (s, 3H, CH3), 1.84 (s, 3H, CH3), 4.98
(s, 1H, CH), 6.95–6.98 (m, 2H, phenyl), 7.16–7.20 (m, 1H,
phenyl), 7.23–7.40 (m, 7H, phenyl). 13C NMR (CD2Cl2) δ 22.50
(CH3), 25.09 (CH3), 96.64 (CH), 125.8, 127.2, 128.0, 128.4,
129.7 (phenyl C), 150.9, 157.8, 159.7, 160.3 (CdN and ipso-
CPhsN), 168.7 (CO). IR (CCl4 solution, cm-1) 2130 (νCO), 1593
(νC)N), (PhCH3 solution, cm-1) 2130 (νCO). The instability of 2
did not allow for elemental analysis.
1
lographic analysis. H NMR (CD2Cl2) δ 1.56 (s, 6H, CH3), 4.66
(s, 1H, CH), 6.74–6.76 (m, 4 H, Ph), 7.00–7.04 (m, 2H, Ph),
7.08–7.13 (m, 4H, Ph). 13C NMR (CD2Cl2) δ 23.56 (CH3), 96.38
(CH), 125.9, 127.8, 128.5 (phenyl), 150.7 (CPh-N), 156.6 (CdN).
IR (Nujol, cm-1): 1560 (νC)N). UV–vis (CH2Cl2) 582 nm; 400 (
3 L · mol-1 · cm-1. Anal. Calcd for C34H34Cl2N4Pd2: C, 52.19; H,
4.38; N, 7.16. Found: C, 52.54; H, 4.54; N, 7.21.
Synthesis of [Pd(Ph2nacnac)Cl(L1)] (2). A solution of N-meth-
yl-4,5-diphenylimidazole (L1; 23 mg, 0.1 mmol) in CH2Cl2 (0.5
mL) was added to a dark green solution of 1 (39 mg, 0.05 mmol)
in CH2Cl2 (2 mL). The solution turned red within minutes. The
reaction was stirred for 30 min and the solvent was removed in
vacuo to leave a red residue. The crude product was dissolved in
a minimum amount of ether, filtered through a pad of Celite.
Addition of hexanes precipitated 2 as a red powder, which was
filtered, washed with a small amount of hexanes, and vaccuum-
dried. Yield 87% (55 mg). The crystals suitable for X-ray
crystallographic analysis were grown by slow diffusion of
hexanes into a concentrated solution of 2 in THF. 1H NMR
(CD2Cl2) δ 1.55 (s, 3H, CH3 nacnac), 1.69 (s, 3H, CH3 nacnac),
3.20 (s, 3H, CH3-N imidazole), 4.70 (s, 1H, CH nacnac),
6.91–6.63 (m, 2H, Ph), 7.00–7.16 (m, 8H, Ph), 7.26 (s, 1H,
N-CH-N imidazole), 7.29–7.39 (m, 8H, Ph), 7.97–8.00 (m,
2H, Ph). 13C NMR (CD2Cl2) δ 23.86 (CH3 nacnac), 24.33 (CH3
nacnac), 33.47 (N-CH3 imidazole), 97.09 (CH nacnac), 124.5,
124.8, 127.3, 127.9, 128.0, 128.1, 128.4, 129.0, 129.3, 129.4,
129.8, 130.6, 130.9, 132.6 (phenyl), 137.0, 139.0 (CdC,
imidazole), 139.0 (NCN, imidazole), 151.6, 153.3, 157.2, 158.2
(ipso-CPhsN and CdN). IR (Nujol, cm-1) 1557 (νC)N). Anal.
Calcd for C33H31ClN4Pd: C, 63.37; H, 5.00; N, 8.96. Found: C,
62.96; H, 5.09; N, 8.74.
Synthesis of [Pd(Ph2nacnac)Cl(L2)] (3). A solution of 4-tert-
butylaniline (L2, 14 mg, 0.1 mmol) in CH2Cl2 (0.5 mL) was
added to a green solution of 1 (39 mg, 0.05 mmol) in CH2Cl2 (2
mL). The solution turned red within minutes. Stirring was
continued for 20 min and the solvents were removed in vacuo
leaving a red solid residue. The crude product was washed with
hexanes and vaccuum-dried to yield 48 mg (90%) of complex
3. 1H NMR (CD2Cl2) δ 1.29 (s, 9H, (CH3)C-), 1.70 (s, 3H,
CH3), 1.71 (s, 3H, CH3), 3.82 (s, br, 2H, NH2), 4.81 (s, 1H,
CH), 6.95–7.00 (m, 2H, phenyl), 7.03–7.07 (m, 4H, Ph),
7.10–7.23 (m, 4H, Ph), 7.25–7.31 (m, 4H, Ph). 13C NMR
(CD2Cl2) δ 23.86 (CH3), 24.39 (CH3), 31.60 (CH3, tert-butyl),
97.59 (CH nacnac), 124.2, 125.0, 125.9, 126.3, 126,5, 127.7,
127.8, 128.0, 128.1, 129.8 (Ph), 137.0, 149.7, 150.4, 153.4,
157.1, 158.6 (ipso-CPhsN and CdN). IR (Nujol, cm-1) 3211,
3304 (νNH). Anal. Calcd for C27H32ClN3Pd: C, 60.01; H, 5.97;
N, 7.78. Found: C, 60.42; H, 6.14; N, 7.71.
Oxidation of 1: Synthesis of [Pd(Ph2nacCl)]2-(µ-OAc)2 (5).
Iodobenzene diacetate (16 mg, 0.05 mmol) in THF (1 mL) was
added dropwise to a solution of 1 (19 mg, 0.025 mmol) in THF
(0.3 mL). The resulting solution was stirred overnight. Hexanes
(4 mL) were added to the red solution producing a small amount
of brown solid, which was removed by filtration through a pad
of Celite. The filtrate was placed in the freezer (-30 °C). The
solvent was decanted from the precipitated product, which was
dried in air to give 5 in 75% yield. The crystals suitable for
X-ray crystallographic analysis were grown by slow diffusion
1
of hexanes into a concentrated solution of 5 in THF. H NMR
(CD2Cl2) δ 0.96 (s, 6H, CH3COO), 2.15 (s, 12H, CH3 nacnac),
7.15–7.17 (m, 8H, aromatic), 7.19–7.23 (m, 4H, aromatic),
7.30–7.34 (m, 8H, aromatic). 13C NMR (CD2Cl2) δ 22.36, 23.30
(nacnac and OAc CH3), 105.1 (CCl), 125.7, 127.9, 128.7
(aromatic), 149.8, 157.3 (ipso-CPhsN and CdN), 182.2 (OCO
acetate). IR (Nujol, cm-1) 1568, 1430 (νOAc). Anal. Calcd for
C38H38Cl2N4O4Pd2: C, 50.80; H, 4.26; N, 6.24. Found: C, 50.79;
H, 4.14; N, 6.18.
Synthesis of [Pd(Ph2nacnac)(L1)2]2-µ-(Cu6Cl8) (6). N-Methyl-
4,5-diphenylimidazole (L1, 46 mg, 0.2 mmol) was added to a stirred
green solution of 1 (39 mg, 0.05 mmol) in dry C6H6 (4 mL) in an
N2-filled glovebox. Within minutes the color of the reaction
mixture changed to red. After 30 min of stirring, CuCl (30 mg,
3mmol) was added and stirring was continued for 4 h. The
slightly cloudy red solution was filtered through a small pad of
Celite. Slow evaporation of the solvent from the filtrate gave
large red crystals of 6 · C6H6 in 45% yield. 1H NMR (CD2Cl2) δ
1.99 (s, 12H, nacnac-CH3), 2.93 (s, 12H, L1-CH3), 5.21 (s, 2H,
ꢀ-CH), 5.53 (s, 4H, imidazole-CH), 6.99–7.04 (m, 8H, aromatic),
7.05–7.14 (m, 12H, aromatic), 7.19 (t, broad, J ) 7.4 Hz, 12H,
aromatic), 7.38–7.50 (m, 14H, aromatic), 7.54–7.62 (m, 12H,
aromatic), 7.80–7.88 (m, 8H, aromatic). 13C NMR (CD2Cl2) δ
24.49, 33.70, 98.55, 125.71, 127.44, 128.20, 128.44, 128.68,
128.75, 128.84, 128.97, 129.64, 129.86, 129.93, 130.86, 132.88,
Synthesis of [Pd(Ph2nacnac)Cl(CO)] (4). The red solutions of
complex 4 can generally be prepared by bubbling CO through a